Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. acmcr [Internet]. 2020 Nov. 20 [cited 2026 Sep. 11];4(6):1108-15. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422